MYCOBUTIN Side Effects

6905539-2 | Loss Of Consciousness
on Jul 27, 2010 Female patient from JAPAN , 30 years of age, was diagnosed with lymph node tuberculosis and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness. Mycobutin dosage: 150 Mg/day. During the same period patient was treated with NELFINAVIR MESILATE (1250 Mg, 2x/day) (View Nelfinavir Mesilate Review and Nelfinavir Mesilate Label ).

6835660-9 | Loss Of Consciousness
Patient was taking Mycobutin (View Usage). Patient had the following side effects: loss of consciousness on Jul 05, 2010 from JAPAN Additional patient health information: Female patient , 30 years of age, was diagnosed with lymph node tuberculosis and. Mycobutin dosage: 150 Mg, Unk. During the same period patient was treated with NELFINAVIR MESILATE (1250 Mg, 2x/day) (View Nelfinavir Mesilate Review and Nelfinavir Mesilate Label ).

6817689-X | Loss Of Consciousness
Adverse event was reported on Jun 28, 2010 by a Female patient taking Mycobutin (View Usage) (Dosage: 150 Mg, Unk) . Location: JAPAN , 35 years of age, After Mycobutin was administered, patient had the following side effects: loss of consciousness. During the same period patient was treated with NELFINAVIR MESILATE (1250 Mg, 2x/day) (View Nelfinavir Mesilate Review and Nelfinavir Mesilate Label ).

6812625-4 | Back Pain, Constipation, Neutropenia, Vomiting
on Jun 21, 2010 Female patient from IRELAND , 58 years of age, was diagnosed with pathogen resistance and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), constipation (What is constipation?), neutropenia, vomiting. Mycobutin dosage: 150 Mg, 2x/day. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.


6788333-5 | Arthralgia, Auricular Swelling, Blood Sodium Decreased, Ear Pain, Fluid Retention, Lip Swelling, Oedema Peripheral, Pain In Extremity, Rash
on Apr 09, 2008 Female patient from UNITED STATES , weighting 159.0 lb, was diagnosed with mycobacterium avium complex infection and was treated with Mycobutin (View Usage). Patient had the following side effects: arthralgia, auricular swelling, blood sodium decreased, ear pain, fluid retention, lip swelling, oedema peripheral, pain in extremity, rash (What is rash?). Mycobutin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), ESKALITH (View Eskalith Review and Eskalith Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).

6760641-3 | Back Pain, Constipation, Neutropenia, Vomiting
Patient was taking Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: back pain (What is back pain?), constipation (What is constipation?), neutropenia, vomiting on May 27, 2010 from IRELAND Additional patient health information: Female patient , 58 years of age, was diagnosed with pathogen resistance and. Mycobutin dosage: 150 Mg, 2x/day. During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ). Patient was hospitalized.

6760589-4 | Jaundice, Transaminases Increased
Adverse event was reported on May 27, 2010 by a Male patient taking Mycobutin (View Usage) (Dosage: 150 Mg, 3x/day) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: GERMANY , 71 years of age, weighting 168.7 lb, Patient experienced the following unwanted or unexpected effects: jaundice (What is jaundice?), transaminases increased. During the same period patient was treated with TAVANIC (500 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), CLARITHROMYCIN (500 Mg, 2x/day) (View Clarithromycin Review and Clarithromycin Label ), CLAVERSAL ^MERCKLE^ (1.5 G, 1x/day) (View Claversal ^merckle^ Review and Claversal ^merckle^ Label ). Patient was hospitalized.

6738581-5 | Condition Aggravated, Mycobacterium Avium Complex Infection
on May 12, 2010 Male patient from JAPAN , 81 years of age, was diagnosed with mycobacterium avium complex infection and was treated with Mycobutin (View Usage). Patient had the following side effects: condition aggravated, mycobacterium avium complex infection. Mycobutin dosage: Unk Mg, Unk. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CRAVIT (View Cravit Review and Cravit Label ).

6712038-X | Cognitive Disorder, Dysstasia, Gait Disturbance, Incoherent
on Apr 29, 2010 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with mycobacterium avium complex infection, cardiac disorder, ulcer (What is ulcer?), ventricular tachycardia, atrial fibrillation (What is atrial fibrillation?), hypertension and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: cognitive disorder, dysstasia, gait disturbance, incoherent. Mycobutin dosage: 150 Mg, 2x/day. During the same period patient was treated with ETHAMBUTOL (400 Mg, 1x/day) (View Ethambutol Review and Ethambutol Label ), BIAXIN (500 Mg, 2x/day) (View Biaxin Review and Biaxin Label ), DIGOXIN (Unk) (View Digoxin Review and Digoxin Label ), PRILOSEC (20 Mg, 1x/day) (View Prilosec Review and Prilosec Label ), ATENOLOL (50 Mg, 2x/day) (View Atenolol Review and Atenolol Label ), COUMADIN (5 Mg, 1x/day) (View Coumadin Review and Coumadin Label ), NORVASC (5 Mg, 1x/day) (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

6711370-3 | Malaise, Pyrexia
Patient was taking Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, pyrexia on Apr 28, 2010 from JAPAN Additional patient health information: Female patient , 57 years of age, was diagnosed with mycobacterium avium complex infection and. Mycobutin dosage: 150 Mg, 1x/day. During the same period patient was treated with KLARICID (Unk) (View Klaricid Review and Klaricid Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ). Patient was hospitalized.

6710015-6 | Immune Reconstitution Syndrome
Adverse event was reported on Apr 26, 2010 by a Male patient taking Mycobutin (View Usage) (Dosage: 150 Mg, Alternate Day) was diagnosed with tuberculosis (What is tuberculosis?), hiv infection (What is hiv infection?) and. Location: JAPAN , 38 years of age, Patient had the following side effects: immune reconstitution syndrome. During the same period patient was treated with TRUVADA (1 Df, 1x/day) (View Truvada Review and Truvada Label ), PREZISTA (200 Mg, 2x/day) (View Prezista Review and Prezista Label ), NORVIR (200 Mg, 2x/day) (View Norvir Review and Norvir Label ), ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ).

6655543-7 | Decreased Appetite, Malaise, Platelet Count Decreased, Pyrexia, White Blood Cell Count Decreased
on Mar 17, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: decreased appetite, malaise, platelet count decreased, pyrexia, white blood cell count decreased. Mycobutin dosage: 150 Mg, 1x/day. During the same period patient was treated with KLARICID (View Klaricid Review and Klaricid Label ), ESANBUTOL (View Esanbutol Review and Esanbutol Label ), KANAMYCIN SULFATE (0.7 G Daily) (View Kanamycin Sulfate Review and Kanamycin Sulfate Label ). Patient was hospitalized.

6644785-2 | Hallucination, Headache
on Mar 10, 2010 Male patient from UNITED KINGDOM , 15 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, headache (What is headache?). Mycobutin dosage: 350 Mg, 1x/day. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), INSULIN (View Insulin Review and Insulin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ).

6636245-X | Jaundice, Transaminases Increased
Patient was taking Mycobutin (View Usage). Patient had the following side effects: jaundice (What is jaundice?), transaminases increased on Mar 04, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, weighting 168.7 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Mycobutin dosage: 150 Mg, 3x/day. During the same period patient was treated with TAVANIC (500 Mg, 1x/day) (View Tavanic Review and Tavanic Label ), CLARITHROMYCIN (500 Mg, 2x/day) (View Clarithromycin Review and Clarithromycin Label ), CLAVERSAL ^MERCKLE^ (1.5 G, 1x/day) (View Claversal ^merckle^ Review and Claversal ^merckle^ Label ). Patient was hospitalized.

6618090-4 | Bladder Pain, Chromaturia, Cystitis, Faeces Discoloured
Adverse event was reported on Feb 26, 2010 by a Female patient taking Mycobutin (View Usage) (Dosage: 150 Mg, 2x/day) was diagnosed with helicobacter infection, hepatitis b (What is hepatitis b?) and. Location: UNITED STATES , weighting 148.0 lb, After Mycobutin was administered, patient had the following side effects: bladder pain, chromaturia, cystitis, faeces discoloured. During the same period patient was treated with AMOXICILLIN (Unk) (View Amoxicillin Review and Amoxicillin Label ), VIREAD (Unk) (View Viread Review and Viread Label ).

6616171-2 | Neutrophil Count Decreased
on Feb 22, 2010 Male patient from JAPAN , 26 years of age, was diagnosed with mycobacterium test, hiv infection (What is hiv infection?) and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. Mycobutin dosage: 300 Mg, 1x/day. During the same period patient was treated with ZITHROMAX (600 Mg, 1x/day) (View Zithromax Review and Zithromax Label ), CLARITH (400 Mg, 1x/day) (View Clarith Review and Clarith Label ), EBUTOL (1000 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), TRUVADA (Unk) (View Truvada Review and Truvada Label ), ISENTRESS (Unk) (View Isentress Review and Isentress Label ). Patient was hospitalized.

6603290-X | Neutrophil Count Decreased
on Feb 15, 2010 Male patient from JAPAN , 26 years of age, was diagnosed with mycobacterium test, hiv infection (What is hiv infection?) and was treated with Mycobutin (View Usage). Patient had the following side effects: neutrophil count decreased. Mycobutin dosage: 300 Mg, 1x/day. During the same period patient was treated with ZITHROMAX (600 Mg, 1x/day) (View Zithromax Review and Zithromax Label ), CLARITH (400 Mg, 1x/day) (View Clarith Review and Clarith Label ), EBUTOL (1000 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), TRUVADA (Unk) (View Truvada Review and Truvada Label ), ISENTRESS (Unk) (View Isentress Review and Isentress Label ). Patient was hospitalized.

6566207-2 | Blood Bilirubin Abnormal
Patient was taking Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: blood bilirubin abnormal on Jan 21, 2010 from JAPAN Additional patient health information: Female patient , 60 years of age, was diagnosed with mycobacterial infection and. Mycobutin dosage: Unk. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ETHAMBUTOL (View Ethambutol Review and Ethambutol Label ).

6564817-X | Joint Swelling
Adverse event was reported on Jan 20, 2010 by a Female patient taking Mycobutin (View Usage) (Dosage: Unk) was diagnosed with mycobacterial infection and. Location: JAPAN , 54 years of age, Patient experienced the following unwanted or unexpected effects: joint swelling. During the same period patient was treated with AVELOX (Unk) (View Avelox Review and Avelox Label ), EBUTOL (500 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), MARZULENE S (Unk) (View Marzulene S Review and Marzulene S Label ).

6436148-X | Joint Swelling, White Blood Cell Count Decreased
on Oct 30, 2009 Female patient from JAPAN , 54 years of age, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). Patient had the following side effects: joint swelling, white blood cell count decreased. Mycobutin dosage: Unk. During the same period patient was treated with AVELOX (Unk) (View Avelox Review and Avelox Label ), EBUTOL (500 Mg, 1x/day) (View Ebutol Review and Ebutol Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), MARZULENE S (Unk) (View Marzulene S Review and Marzulene S Label ).

6393936-6 | Erythema Multiforme, Vision Blurred
on Sep 25, 2009 Female patient from JAPAN , 73 years of age, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: erythema multiforme, vision blurred. Mycobutin dosage: 300 Mg, 1x/day. During the same period patient was treated with ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), CRAVIT (Unk) (View Cravit Review and Cravit Label ).

6371350-7 | Chills, Fluid Intake Reduced, Gastrointestinal Disorder, Hepatitis, Leukopenia, Myalgia, Nausea, Neutropenia, Pain
Patient was taking Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, fluid intake reduced, gastrointestinal disorder, hepatitis (What is hepatitis?), leukopenia, myalgia, nausea (What is nausea?), neutropenia, pain (What is pain?) on Sep 09, 2009 from AUSTRALIA Additional patient health information: Female patient , 41 years of age, was diagnosed with helicobacter infection, reflux oesophagitis and. Mycobutin dosage: 300 Mg 1x/day. During the same period patient was treated with DOXYLIN ^ALPHAPHARM^ (100 Mg, 2x/day) (View Doxylin ^alphapharm^ Review and Doxylin ^alphapharm^ Label ), PARIET (20 Mg, 2x/day) (View Pariet Review and Pariet Label ), LOVAN (2 Weeks Of Month) (View Lovan Review and Lovan Label ). Patient was hospitalized.

6349519-7 | Mycobacterium Avium Complex Infection
Adverse event was reported on Sep 02, 2009 by a Female patient taking Mycobutin (View Usage) (Dosage: 1 Df, Single) was diagnosed with mycobacterium avium complex infection and. Location: JAPAN , 65 years of age, Patient had the following side effects: mycobacterium avium complex infection.

6341741-9 | Erythema Multiforme, Vision Blurred
on Aug 24, 2009 Female patient from JAPAN , 73 years of age, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: erythema multiforme, vision blurred. Mycobutin dosage: 300 Mg, 1x/day. During the same period patient was treated with ESANBUTOL (Unk) (View Esanbutol Review and Esanbutol Label ), LEVOFLOXACIN (Unk) (View Levofloxacin Review and Levofloxacin Label ).

6332217-3 | Chills, Myalgia, Nausea, Neutropenia, Pain
on Aug 18, 2009 Female patient from AUSTRALIA , 41 years of age, was diagnosed with helicobacter infection and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: chills, myalgia, nausea (What is nausea?), neutropenia, pain (What is pain?). Mycobutin dosage: 300 Mg 1x/day. During the same period patient was treated with DOXYLIN ^ALPHAPHARM^ (100 Mg, 2x/day) (View Doxylin ^alphapharm^ Review and Doxylin ^alphapharm^ Label ), PARIET (20 Mg, 2x/day) (View Pariet Review and Pariet Label ). Patient was hospitalized.

6317976-8 | Neuroleptic Malignant Syndrome
Patient was taking Mycobutin (View Usage). Patient had the following side effects: neuroleptic malignant syndrome on Aug 10, 2009 from JAPAN Additional patient health information: Female patient , 61 years of age, . Mycobutin dosage: . During the same period patient was treated with PROMETHAZINE HCL (Unk) (View Promethazine Hcl Review and Promethazine Hcl Label ), MAGNESIUM OXIDE (Unk) (View Magnesium Oxide Review and Magnesium Oxide Label ), BROVARIN (Unk) (View Brovarin Review and Brovarin Label ), BARBITAL (Unk) (View Barbital Review and Barbital Label ), BENZALIN (Unk) (View Benzalin Review and Benzalin Label ), NEULEPTIL (Unk) (View Neuleptil Review and Neuleptil Label ), AMINOSALICYLATE CALCIUM (Unk) (View Aminosalicylate Calcium Review and Aminosalicylate Calcium Label ), CYCLOSERINE (2 Capsules/day) (View Cycloserine Review and Cycloserine Label ).

6268554-0 | Liver Function Test Abnormal
Adverse event was reported on Jul 07, 2009 by a Female patient taking Mycobutin (View Usage) (Dosage: ) . Location: JAPAN , 69 years of age, After Mycobutin was administered, patient had the following side effects: liver function test abnormal. During the same period patient was treated with SITAFLOXACIN (View Sitafloxacin Review and Sitafloxacin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), GRIMAC (AZULENE SULFONATE SODIUM/L GLUTAMINE) (View Grimac (azulene Sulfonate Sodium/l-glutamine) Review and Grimac (azulene Sulfonate Sodium/l-glutamine) Label ), BIOFERMIN R (ANTIBIOTICS RESISTANT LACTIC ACID BACTERIAE) (View Biofermin-r (antibiotics-resistant Lactic Acid Bacteriae) Review and Biofermin-r (antibiotics-resistant Lactic Acid Bacteriae) Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), CINAL (ASCORBIC ACID/CALCIUM PANTOTHENATE) (View Cinal (ascorbic Acid/calcium Pantothenate) Review and Cinal (ascorbic Acid/calcium Pantothenate) Label ), ADONA (CARBAZOCHROME SODIUM SULFONATE HYDRATE) (View Adona (carbazochrome Sodium Sulfonate Hydrate) Review and Adona (carbazochrome Sodium Sulfonate Hydrate) Label ), ROHYPNOL (FLUNITRAZEPAM) (View Rohypnol (flunitrazepam) Review and Rohypnol (flunitrazepam) Label ).

6257258-6 | Myalgia, Polymyalgia Rheumatica, Pyrexia
on Jun 24, 2009 Female patient from JAPAN , 65 years of age, was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: myalgia, polymyalgia rheumatica (What is polymyalgia rheumatica?), pyrexia. Mycobutin dosage: Unk. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ).

6247194-3 | Myalgia, Polymyalgia Rheumatica, Pyrexia
on Jun 16, 2009 Female patient from JAPAN , 65 years of age, was treated with Mycobutin (View Usage). Patient had the following side effects: myalgia, polymyalgia rheumatica (What is polymyalgia rheumatica?), pyrexia. Mycobutin dosage: Unk. During the same period patient was treated with PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ), RIFAMPICIN (Unk) (View Rifampicin Review and Rifampicin Label ).

6217934-8 | Liver Disorder
Patient was taking Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: liver disorder on May 27, 2009 from JAPAN Additional patient health information: Female patient , 82 years of age, was diagnosed with mycobacterial infection and. Mycobutin dosage: Unk. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ).

6213601-5 | Polymyalgia Rheumatica
Adverse event was reported on May 22, 2009 by a Female patient taking Mycobutin (View Usage) (Dosage: Unk) . Location: JAPAN , 65 years of age, Patient experienced the following unwanted or unexpected effects: polymyalgia rheumatica (What is polymyalgia rheumatica?).

6209946-5 | Arrhythmia, Back Pain, Leukopenia, Pyrexia
on May 18, 2009 Female patient from GERMANY , 57 years of age, was diagnosed with helicobacter infection and was treated with Mycobutin (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), back pain (What is back pain?), leukopenia, pyrexia. Mycobutin dosage: 300mg Daily. During the same period patient was treated with OMEPRAZOL (Unk) (View Omeprazol Review and Omeprazol Label ), TAVANIC (Unk) (View Tavanic Review and Tavanic Label ).

5971425-8 | Altered State Of Consciousness, Anxiety, Blood Magnesium Decreased, Depression, Diarrhoea, Neck Pain, Oral Pain, Psychiatric Symptom, Thirst
on Nov 26, 2008 Female patient from JAPAN , 88 years of age, was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: altered state of consciousness, anxiety (What is anxiety?), blood magnesium decreased, depression (What is depression?), diarrhoea, neck pain, oral pain, psychiatric symptom, thirst. Mycobutin dosage: Daily Dose:300mg. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), CORTRIL (View Cortril Review and Cortril Label ), CYCLOSERINE (View Cycloserine Review and Cycloserine Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5964365-1 | Respiratory Arrest, Sputum Retention
Patient was taking Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory arrest, sputum retention on Nov 12, 2008 from JAPAN Additional patient health information: Male patient , 63 years of age, was diagnosed with atypical mycobacterial infection, chronic obstructive pulmonary disease and. Mycobutin dosage: Daily Dose:150mg. During the same period patient was treated with MEDICON (View Medicon Review and Medicon Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), TULOBUTEROL (View Tulobuterol Review and Tulobuterol Label ), MUCOSOLVAN (View Mucosolvan Review and Mucosolvan Label ), CRAVIT (View Cravit Review and Cravit Label ), ALFAROL (View Alfarol Review and Alfarol Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ).

5962506-3 | Altered State Of Consciousness, Anxiety, Blood Magnesium Decreased, Depression, Diarrhoea, Neck Pain, Oral Pain, Psychiatric Symptom, Thirst
Adverse event was reported on Nov 11, 2008 by a Female patient taking Mycobutin (View Usage) (Dosage: Daily Dose:300mg) . Location: JAPAN , 88 years of age, Patient had the following side effects: altered state of consciousness, anxiety (What is anxiety?), blood magnesium decreased, depression (What is depression?), diarrhoea, neck pain, oral pain, psychiatric symptom, thirst. During the same period patient was treated with DEPAS (View Depas Review and Depas Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), CORTRIL (View Cortril Review and Cortril Label ), CYCLOSERINE (View Cycloserine Review and Cycloserine Label ), TOLEDOMIN (View Toledomin Review and Toledomin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).

5958650-7 | Interstitial Lung Disease
on Nov 07, 2008 Male patient from JAPAN , 69 years of age, was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: interstitial lung disease. Mycobutin dosage: . During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ).

5958646-5 | Anaemia, Pyrexia, Renal Impairment
on Nov 07, 2008 Male patient from JAPAN , 73 years of age, was diagnosed with tuberculosis (What is tuberculosis?) and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, pyrexia, renal impairment. Mycobutin dosage: .

5834516-8 | Jaundice
Patient was taking Mycobutin (View Usage). Patient had the following side effects: jaundice (What is jaundice?) on Jul 24, 2008 from BELGIUM Additional patient health information: Female patient , 59 years of age, . Mycobutin dosage: .

5802030-1 | Asthenia, Chills, Malaise, Medical Device Complication, Nausea, Oral Discomfort, Platelet Count Decreased, Rectal Haemorrhage, Urticaria
Adverse event was reported on Jun 25, 2008 by a Female patient taking Mycobutin (View Usage) (Dosage: ) was diagnosed with mycobacterium avium complex infection and. Location: UNITED STATES , weighting 127.0 lb, After Mycobutin was administered, patient had the following side effects: asthenia, chills, malaise, medical device complication, nausea (What is nausea?), oral discomfort, platelet count decreased, rectal haemorrhage, urticaria. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5780699-8 | Asthenia, Chills, Malaise, Nausea, Oral Discomfort, Platelet Count Decreased, Rectal Haemorrhage, Urticaria, White Blood Cell Count Decreased
on Jun 09, 2008 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with mycobacterium avium complex infection and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, chills, malaise, nausea (What is nausea?), oral discomfort, platelet count decreased, rectal haemorrhage, urticaria, white blood cell count decreased. Mycobutin dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5740838-1 | Asthenia, Chills, Dehydration, Nausea, Oral Discomfort, Platelet Count Decreased, Rectal Haemorrhage, Urticaria, White Blood Cell Count Decreased
on May 06, 2008 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with mycobacterium avium complex infection and was treated with Mycobutin (View Usage). Patient had the following side effects: asthenia, chills, dehydration, nausea (What is nausea?), oral discomfort, platelet count decreased, rectal haemorrhage, urticaria, white blood cell count decreased. Mycobutin dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5717060-8 | Asthenia, Chills, Dehydration, Nausea, Oral Discomfort, Platelet Count Decreased, Urticaria, White Blood Cell Count Decreased
Patient was taking Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: asthenia, chills, dehydration, nausea (What is nausea?), oral discomfort, platelet count decreased, urticaria, white blood cell count decreased on Apr 14, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 127.0 lb, was diagnosed with mycobacterium avium complex infection and. Mycobutin dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5669871-5 | Asthenia, Chills, Dehydration, Nausea, Oral Discomfort, Platelet Count Decreased, Urticaria, White Blood Cell Count Decreased
Adverse event was reported on Mar 05, 2008 by a Female patient taking Mycobutin (View Usage) (Dosage: ) was diagnosed with mycobacterium avium complex infection and. Location: UNITED STATES , weighting 127.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, chills, dehydration, nausea (What is nausea?), oral discomfort, platelet count decreased, urticaria, white blood cell count decreased. During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5610180-8 | Asthenia, Dehydration, Nausea, Oral Discomfort, Platelet Count Decreased, Urticaria, White Blood Cell Count Decreased
on Jan 19, 2008 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with mycobacterium avium complex infection and was treated with Mycobutin (View Usage). Patient had the following side effects: asthenia, dehydration, nausea (What is nausea?), oral discomfort, platelet count decreased, urticaria, white blood cell count decreased. Mycobutin dosage: . During the same period patient was treated with AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

5319137-8 | Myalgia, White Blood Cell Count Decreased
on Oct 30, 2006 Female patient from UNITED STATES , 49 years of age, weighting 245.0 lb, was diagnosed with helicobacter infection and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: myalgia, white blood cell count decreased. Mycobutin dosage: 300 Mg (150 Mg, 2 In 1 D). During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), NEXIUM (View Nexium Review and Nexium Label ), BISMUTH (BISMUTH) (View Bismuth (bismuth) Review and Bismuth (bismuth) Label ). Patient was hospitalized.

5122312-9 | Headache, Incorrect Dose Administered, Neuralgia
Patient was taking Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), incorrect dose administered, neuralgia on Sep 20, 2006 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 190.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Mycobutin dosage: . During the same period patient was treated with INTRON A (View Intron A Review and Intron A Label ), REBETOL (View Rebetol Review and Rebetol Label ), PEGINTERFERON ALFA 2B (View Peginterferon Alfa-2b Review and Peginterferon Alfa-2b Label ).

5018367-2 | Dyspnoea, Weight Decreased
Adverse event was reported on May 16, 2006 by a Male patient taking Mycobutin (View Usage) (Dosage: 300 Mg (300 Mg, 1 In 1 D), Oral) was diagnosed with ill-defined disorder and. Location: UNITED STATES , 70 years of age, Patient had the following side effects: dyspnoea, weight decreased. During the same period patient was treated with CLARITHROMYCIN (CLARITHROMCIN) (View Clarithromycin (clarithromcin) Review and Clarithromycin (clarithromcin) Label ).

4866927-1 | Anaemia, Bone Marrow Disorder, Erythropoiesis Abnormal, White Blood Cell Morphology Abnormal
on Dec 12, 2005 Female patient from AUSTRIA , 32 years of age, weighting 132.3 lb, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). After Mycobutin was administered, patient had the following side effects: anaemia, bone marrow disorder, erythropoiesis abnormal, white blood cell morphology abnormal. Mycobutin dosage: 600 Mg (150 Mg, 2 In 2 D), Oral. During the same period patient was treated with ALEXAN (CYTARABINE) (View Alexan (cytarabine) Review and Alexan (cytarabine) Label ), ORGAMETRIL (LYNESTRENOL) (View Orgametril (lynestrenol) Review and Orgametril (lynestrenol) Label ), KLACID (CLARITHROMYCIN) (View Klacid (clarithromycin) Review and Klacid (clarithromycin) Label ), CIPROXIN (CIPROFLOXACIN) (View Ciproxin (ciprofloxacin) Review and Ciproxin (ciprofloxacin) Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), PANTOLOC ^BYK^ (PANTOPRAZOLE SODIUM) (View Pantoloc ^byk^ (pantoprazole Sodium) Review and Pantoloc ^byk^ (pantoprazole Sodium) Label ).

4853338-8 | Myelodysplastic Syndrome, Post Procedural Complication
on Nov 29, 2005 Female patient from AUSTRIA , 32 years of age, weighting 132.3 lb, was diagnosed with mycobacterial infection and was treated with Mycobutin (View Usage). Patient experienced the following unwanted or unexpected effects: myelodysplastic syndrome, post procedural complication. Mycobutin dosage: 600 Mg (150 Mg, 2 In 2 D), Oral. During the same period patient was treated with ALEXAN (CYTARABINE) (View Alexan (cytarabine) Review and Alexan (cytarabine) Label ), ORGAMETRIL (LYNESTRENOL) (View Orgametril (lynestrenol) Review and Orgametril (lynestrenol) Label ), KLACID (CLARITHROMYCIN) (View Klacid (clarithromycin) Review and Klacid (clarithromycin) Label ), CIPROXIN (CIPROFLOXACIN) (View Ciproxin (ciprofloxacin) Review and Ciproxin (ciprofloxacin) Label ), ZOVIRAX (View Zovirax Review and Zovirax Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

4676587-0 | Hypopyon, Iridocyclitis, Macular Oedema, Photophobia, Visual Acuity Reduced
Patient was taking Mycobutin (View Usage). Patient had the following side effects: hypopyon, iridocyclitis, macular oedema, photophobia, visual acuity reduced on May 13, 2005 from Additional patient health information: Female patient , 56 years of age, was diagnosed with mycobacterium avium complex infection and. Mycobutin dosage: 300 Mg (150 Mg, Bid). During the same period patient was treated with ETHAMBUTOL (ETHAMBUTOL) (800 Mg (400 Mg, Bid)) (View Ethambutol (ethambutol) Review and Ethambutol (ethambutol) Label ), CLARITHROMYCIN (1000 Mg (500 Mg, Bid)) (View Clarithromycin Review and Clarithromycin Label ), CORTICOSTEROID NOS (CORTICOSTEROID NOS) (View Corticosteroid Nos (corticosteroid Nos) Review and Corticosteroid Nos (corticosteroid Nos) Label ), BETA BLOCKING AGENTS (BETA BLOCKING AGENTS) (View Beta Blocking Agents (beta Blocking Agents) Review and Beta Blocking Agents (beta Blocking Agents) Label ), ANTIINFLAMMATORY / ANTIRHEUMATIC PRODUCTS (ANTIINFLAMAMTORY / ANTIRHEU (View Antiinflammatory / Antirheumatic Products (antiinflamamtory / Antirheu Review and Antiinflammatory / Antirheumatic Products (antiinflamamtory / Antirheu Label ).